Anti-NMDA receptor encephalitis associated with ovarian tumor: the gynecologist point of view.
Anti-NMDA receptor encephalitis
Gynecologic oncology
Gynecologic surgery
Immature ovarian teratoma
Ovarian teratoma
Journal
Archives of gynecology and obstetrics
ISSN: 1432-0711
Titre abrégé: Arch Gynecol Obstet
Pays: Germany
ID NLM: 8710213
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
received:
20
03
2020
accepted:
09
06
2020
pubmed:
20
6
2020
medline:
29
9
2020
entrez:
20
6
2020
Statut:
ppublish
Résumé
Anti-NMDA receptor antibody (anti-NMDAr) encephalitis, although still a rare condition, is well known to neurologists as it is the leading cause of non-infectious acute encephalitis in young women. However, this is less well known to gynecologists, who may have a decisive role in etiological management. Indeed, in 30-60% of cases in women of childbearing age, it is associated with the presence of an ovarian teratoma, whose removal is crucial in the resolution of symptomatology. Primary objective of our work was to present a review in a very schematic and practical way for gynecologists, about the data on anti-NMDAr encephalitis in terms of epidemiology, clinical symptomatology, treatment and prognosis. The second objective was to propose a decision tree for gynecologists to guide them, in collaboration with neurologists and anesthesiologists, after the diagnosis of NMDAr encephalitis associated with an ovarian mass. We conducted an exhaustive review of existing data using PubMed and The Cochrane Library. Then, we illustrated this topic by presenting two typical cases from our experience. Anti-NMDA antibody encephalitis association with an ovarian teratoma is common, especially in women of reproductive age. Complementary examinations in search of an ovarian teratoma must therefore be systematic to envisage a possible surgical excision that may improve patient prognosis. Anti-NMDA antibody encephalitis should not be ignored by gynecologists whose role in management is central.
Sections du résumé
BACKGROUND
Anti-NMDA receptor antibody (anti-NMDAr) encephalitis, although still a rare condition, is well known to neurologists as it is the leading cause of non-infectious acute encephalitis in young women. However, this is less well known to gynecologists, who may have a decisive role in etiological management. Indeed, in 30-60% of cases in women of childbearing age, it is associated with the presence of an ovarian teratoma, whose removal is crucial in the resolution of symptomatology.
OBJECTIVES
Primary objective of our work was to present a review in a very schematic and practical way for gynecologists, about the data on anti-NMDAr encephalitis in terms of epidemiology, clinical symptomatology, treatment and prognosis. The second objective was to propose a decision tree for gynecologists to guide them, in collaboration with neurologists and anesthesiologists, after the diagnosis of NMDAr encephalitis associated with an ovarian mass.
METHOD
We conducted an exhaustive review of existing data using PubMed and The Cochrane Library. Then, we illustrated this topic by presenting two typical cases from our experience.
RESULTS
Anti-NMDA antibody encephalitis association with an ovarian teratoma is common, especially in women of reproductive age. Complementary examinations in search of an ovarian teratoma must therefore be systematic to envisage a possible surgical excision that may improve patient prognosis.
CONCLUSION
Anti-NMDA antibody encephalitis should not be ignored by gynecologists whose role in management is central.
Identifiants
pubmed: 32556515
doi: 10.1007/s00404-020-05645-9
pii: 10.1007/s00404-020-05645-9
doi:
Substances chimiques
Antibodies
0
Receptors, N-Methyl-D-Aspartate
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
315-320Références
Dalmau J, Tüzün E, Wu H, Masjuan J, Rossi JE, Voloschin A et al (2007) Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 61(1):25–36
doi: 10.1002/ana.21050
Hughes EG, Peng X, Gleichman AJ, Lai M, Zhou L, Tsou R et al (2010) Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci 30(17):5866–5875
doi: 10.1523/JNEUROSCI.0167-10.2010
Wu Y-Y, He X-J, Zhang M-L, Shi Y-Y, Zhang J-W (2016) Anti-N-methyl-D-aspartate receptor encephalitis with lung adenocarcinoma. Neurol Sci 37(9):1573–1575
doi: 10.1007/s10072-016-2563-4
Jeraiby M, Depincé-Berger A, Bossy V, Antoine JC, Paul S (2016) A case of anti-NMDA receptor encephalitis in a woman with a NMDA-R(+) small cell lung carcinoma (SCLC). Clin Immunol 166–167:96–99
doi: 10.1016/j.clim.2016.03.011
Zandi MS, Irani SR, Follows G, Moody AM, Molyneux P, Vincent A (2009) Limbic encephalitis associated with antibodies to the NMDA receptor in Hodgkin lymphoma. Neurology 73(23):2039–2040
doi: 10.1212/WNL.0b013e3181c55e9b
Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M et al (2008) Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 7(12):1091–1098
doi: 10.1016/S1474-4422(08)70224-2
Bost C, Chanson E, Picard G, Meyronet D, Mayeur M-E, Ducray F et al (2018) Malignant tumors in autoimmune encephalitis with anti-NMDA receptor antibodies. J Neurol 265:2190–2200
doi: 10.1007/s00415-018-8970-0
Vitaliani R, Mason W, Ances B, Zwerdling T, Jiang Z, Dalmau J (2005) Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma. Ann Neurol 58(4):594–604
doi: 10.1002/ana.20614
Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R (2011) Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 10(1):63–74
doi: 10.1016/S1474-4422(10)70253-2
Granerod J, Ambrose HE, Davies NW, Clewley JP, Walsh AL, Morgan D et al (2010) Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis 10(12):835–844
doi: 10.1016/S1473-3099(10)70222-X
Gable MS, Sheriff H, Dalmau J, Tilley DH, Glaser CA (2012) The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project. Clin Infect Dis 54(7):899–904
doi: 10.1093/cid/cir1038
Dai Y, Zhang J, Ren H, Zhou X, Chen J, Cui L et al (2019) Surgical outcomes in patients with anti-N-methyl-D-aspartate receptor encephalitis with ovarian teratoma. Am J Obstet Gynecol 221(5):485.e1–485.e10
doi: 10.1016/j.ajog.2019.05.026
Viaccoz A, Desestret V, Ducray F, Picard G, Cavillon G, Rogemond V et al (2014) Clinical specificities of adult male patients with NMDA receptor antibodies encephalitis. Neurology 82(7):556–563
doi: 10.1212/WNL.0000000000000126
Kleinig TJ, Thompson PD, Matar W, Duggins A, Kimber TE, Morris JG et al (2008) The distinctive movement disorder of ovarian teratoma-associated encephalitis. Mov Disord 23(9):1256–1261
doi: 10.1002/mds.22073
Iizuka T, Sakai F, Ide T, Monzen T, Yoshii S, Iigaya M et al (2008) Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Neurology 70(7):504–511
doi: 10.1212/01.wnl.0000278388.90370.c3
Sansing LH, Tüzün E, Ko MW, Baccon J, Lynch DR, Dalmau J (2007) A patient with encephalitis associated with NMDA receptor antibodies. Nat Clin Pract Neurol 3(5):291–296
doi: 10.1038/ncpneuro0493
de Montmollin E, Demeret S, Brulé N, Conrad M, Dailler F, Lerolle N et al (2017) Anti-N-methyl-D-Aspartate receptor encephalitis in adult patients requiring intensive care. Am J Respir Crit Care Med 195(4):491–499
doi: 10.1164/rccm.201603-0507OC
Florance NR, Davis RL, Lam C, Szperka C, Zhou L, Ahmad S et al (2009) Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol 66(1):11–18
doi: 10.1002/ana.21756
Lewis P, Glaser CA (2005) Encephalitis. Pediatr Rev 26(10):353–363
doi: 10.1542/pir.26-10-353
Lwanga A, Kamson DO, Wilkins TE, Sharma V, Schulte JJ, Miller J et al (2018) Occult teratoma in a case of N-methyl-D-aspartate receptor encephalitis. Neuroradiol J 31(4):415–419
doi: 10.1177/1971400918763578
Abdul-Rahman ZM, Panegyres PK, Roeck M, Hawkins D, Bharath J, Grolman P et al (2016) Anti-N-methyl-D-aspartate receptor encephalitis with an imaging-invisible ovarian teratoma: a case report. J Med Case Rep 10(1):296
doi: 10.1186/s13256-016-1067-4
Cleverly K, Gambadauro P, Navaratnarajah R (2014) Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis: have you checked the ovaries? Acta Obstet Gynecol Scand 93(7):712–715
doi: 10.1111/aogs.12386
Frawley KJ, Calvo-Garcia MA, Krueger DA, McMasters RL (2012) “Benign” ovarian teratoma and N-methyl-D-aspartate receptor (NMDAR) encephalitis in a child. Pediatr Radiol 42(1):120–123
doi: 10.1007/s00247-011-2111-6
Jones BP, Rees R, Saso S, Stalder C, Smith JR, Yazbek J (2017) Ultrasound-guided laparoscopic ovarian preserving surgery to treat anti-NMDA receptor encephalitis. BJOG 124(2):337–341
doi: 10.1111/1471-0528.14214
Hayashi M, Motegi E, Honma K, Masawa N, Sakuta H, Hirata K et al (2014) Successful laparoscopic resection of 7 mm ovarian mature cystic teratoma associated with anti-NMDAR encephalitis. Case Rep Obstet Gynecol 2014:618742
pubmed: 24959363
pmcid: 4053262
Lapébie F-X, Kennel C, Magy L, Projetti F, Honnorat J, Pichon N et al (2014) Potential side effect of propofol and sevoflurane for anesthesia of anti-NMDA-R encephalitis. BMC Anesthesiol 14:5
doi: 10.1186/1471-2253-14-5
Kingston S, Mao L, Yang L, Arora A, Fibuch EE, Wang JQ (2006) Propofol inhibits phosphorylation of N-methyl-D-aspartate receptor NR1 subunits in neurons. Anesthesiology 104(4):763–769
doi: 10.1097/00000542-200604000-00021
Leel N, Thakkar HS, Drake D, Bouhadiba N (2018) Ovarian teratoma associated with anti-NMDA (N-methyl D-aspartate) receptor encephalitis. BMJ Case Rep 31:429–437
Abuzaid M, Alomar O, Salem H (2018) Paraneoplastic teratoma-associated anti-N-methyl-D-aspartate receptor encephalitis: the first published report from Saudi Arabia. Cureus 10(10):e3527
pubmed: 30648062
pmcid: 6318106
Doden T, Sekijima Y, Ikeda J, Ozawa K, Ohashi N, Kodaira M et al (2017) Postpartum anti-N-methyl-D-aspartate receptor encephalitis: a case report and literature review. Intern Med 56(3):357–362
doi: 10.2169/internalmedicine.56.7442
Masghati S, Nosratian M, Dorigo O (2014) Anti-N-methyl-aspartate receptor encephalitis in identical twin sisters: role for oophorectomy. Obstet Gynecol 123(2 Pt 2 Suppl 2):433–435
doi: 10.1097/AOG.0000000000000078
Balu R, McCracken L, Lancaster E, Graus F, Dalmau J, Titulaer MJ (2019) A score that predicts 1-year functional status in patients with anti-NMDA receptor encephalitis. Neurology 92(3):e244–e252
doi: 10.1212/WNL.0000000000006783
Aungsumart S, Ha A, Apiwattanakul M (2019) Abnormal level of consciousness predicts outcomes of patients with anti-NMDA encephalitis. J Clin Neurosci 62:184–187
doi: 10.1016/j.jocn.2018.11.033
Gresa-Arribas N, Titulaer MJ, Torrents A, Aguilar E, McCracken L, Leypoldt F et al (2014) Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol 13(2):167–177
doi: 10.1016/S1474-4422(13)70282-5
Titulaer MJ, McCracken L, Gabilondo I, Armangué T, Glaser C, Iizuka T et al (2013) Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 12(2):157–165
doi: 10.1016/S1474-4422(12)70310-1
Uchida Y, Kato D, Yamashita Y, Ozaki Y, Matsukawa N (2018) Failure to improve after ovarian resection could be a marker of recurrent ovarian teratoma in anti-NMDAR encephalitis: a case report. Neuropsychiatr Dis Treat 14:339–342
doi: 10.2147/NDT.S156603